IGFBP5 and amyotrophic lateral sclerosis: This is a novel syndrome of growth retardation that presents with progressive growth failure with markedly elevated circulating IGF‐I, IGF‐II, IGFBP‐3, IGFBP‐5, and ALS, but decreased fIGF‐I levels and IGF bioactivity.